254 related articles for article (PubMed ID: 2572027)
1. SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade?
Acquas E; Carboni E; Leone P; Di Chiara G
Psychopharmacology (Berl); 1989; 99(2):151-5. PubMed ID: 2572027
[TBL] [Abstract][Full Text] [Related]
2. Blockade of acquisition of drug-conditioned place aversion by 5HT3 antagonists.
Acquas E; Carboni E; Garau L; Di Chiara G
Psychopharmacology (Berl); 1990; 100(4):459-63. PubMed ID: 2320706
[TBL] [Abstract][Full Text] [Related]
3. Diazepam-induced place preference conditioning: appetitive and antiaversive properties.
Spyraki C; Kazandjian A; Varonos D
Psychopharmacology (Berl); 1985; 87(2):225-32. PubMed ID: 3931151
[TBL] [Abstract][Full Text] [Related]
4. D1 receptor blockade stereospecifically impairs the acquisition of drug-conditioned place preference and place aversion.
Acquas E; Di Chiara G
Behav Pharmacol; 1994 Oct; 5(6):555-569. PubMed ID: 11224235
[TBL] [Abstract][Full Text] [Related]
5. Effects of calcium channel antagonists on the motivational effects of nicotine and morphine in conditioned place aversion paradigm.
Budzynska B; Polak P; Biala G
Behav Brain Res; 2012 Mar; 228(1):144-50. PubMed ID: 22178315
[TBL] [Abstract][Full Text] [Related]
6. Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice.
Manzanedo C; Aguilar MA; Rodríguez-Arias M; Miñarro J
Behav Brain Res; 2001 Jun; 121(1-2):189-97. PubMed ID: 11275296
[TBL] [Abstract][Full Text] [Related]
7. Blockade of D-1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning.
Leone P; Di Chiara G
Eur J Pharmacol; 1987 Mar; 135(2):251-4. PubMed ID: 3556198
[TBL] [Abstract][Full Text] [Related]
8. Effects of dopamine receptor antagonists on the acquisition of ethanol-induced conditioned place preference in mice.
Pina MM; Cunningham CL
Psychopharmacology (Berl); 2014 Feb; 231(3):459-68. PubMed ID: 24005528
[TBL] [Abstract][Full Text] [Related]
9. Morphine-induced place preference in the CXBK mouse: characteristics of mu opioid receptor subtypes.
Suzuki T; Funada M; Narita M; Misawa M; Nagase H
Brain Res; 1993 Jan; 602(1):45-52. PubMed ID: 8383571
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic characterization of nicotine-induced conditioned place preference.
Fudala PJ; Teoh KW; Iwamoto ET
Pharmacol Biochem Behav; 1985 Feb; 22(2):237-41. PubMed ID: 2858867
[TBL] [Abstract][Full Text] [Related]
11. A role for the mesolimbic dopamine system in the reinforcing properties of diazepam.
Spyraki C; Fibiger HC
Psychopharmacology (Berl); 1988; 94(1):133-7. PubMed ID: 3126522
[TBL] [Abstract][Full Text] [Related]
12. Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists.
Shippenberg TS; Herz A
Eur J Pharmacol; 1988 Jul; 151(2):233-42. PubMed ID: 2844553
[TBL] [Abstract][Full Text] [Related]
13. Sensitization to the rewarding effects of morphine depends on dopamine.
Manzanedo C; Aguilar MA; Rodríguez-Arias M; Miñarro J
Neuroreport; 2005 Feb; 16(2):201-5. PubMed ID: 15671878
[TBL] [Abstract][Full Text] [Related]
14. Nicotine attenuates place aversion induced by naloxone in single-dose, morphine-treated rats.
Araki H; Kawakami KY; Jin C; Suemaru K; Kitamura Y; Nagata M; Futagami K; Shibata K; Kawasaki H; Gomita Y
Psychopharmacology (Berl); 2004 Feb; 171(4):398-404. PubMed ID: 13680070
[TBL] [Abstract][Full Text] [Related]
15. Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and kappa-opioid agonists.
Shippenberg TS; Herz A
Brain Res; 1987 Dec; 436(1):169-72. PubMed ID: 2961413
[TBL] [Abstract][Full Text] [Related]
16. Rewarding and aversive effects of nicotine are segregated within the nucleus accumbens.
Sellings LH; Baharnouri G; McQuade LE; Clarke PB
Eur J Neurosci; 2008 Jul; 28(2):342-52. PubMed ID: 18702705
[TBL] [Abstract][Full Text] [Related]
17. Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice.
Sakoori K; Murphy NP
Psychopharmacology (Berl); 2004 Mar; 172(2):129-36. PubMed ID: 14624329
[TBL] [Abstract][Full Text] [Related]
18. Motivational effects of opiates in conditioned place preference and aversion paradigm--a study in three inbred strains of mice.
Solecki W; Turek A; Kubik J; Przewlocki R
Psychopharmacology (Berl); 2009 Dec; 207(2):245-55. PubMed ID: 19787337
[TBL] [Abstract][Full Text] [Related]
19. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
Stinus L; Cador M; Zorrilla EP; Koob GF
Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
[TBL] [Abstract][Full Text] [Related]
20. A test of the opponent-process theory of motivation using lesions that selectively block morphine reward.
Vargas-Perez H; Ting-A-Kee RA; Heinmiller A; Sturgess JE; van der Kooy D
Eur J Neurosci; 2007 Jun; 25(12):3713-8. PubMed ID: 17610590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
